Je-Jung Lee

Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)

Kihyun Kim, J. Lee, K. Yoo, 2023, Annals of Hematology.

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia

J. Cheong, Jae-Sook Ahn, J. Moon, 2024, Scientific reports.

Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT

C. Hong, S. Jeong, Kihyun Kim, 2021, Blood Cancer Journal.